| Dorit E Zilberman, MD | |
|
1000 Trent Dr, Durham, NC 27710-0001 | |
| (919) 684-8111 | |
| Not Available |
| Full Name | Dorit E Zilberman |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Location | 1000 Trent Dr, Durham, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841443322 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2008-01267 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dorit E Zilberman, MD 4101 N Roxboro St, Durham, NC 27704-2121 Ph: (919) 684-8111 | Dorit E Zilberman, MD 1000 Trent Dr, Durham, NC 27710-0001 Ph: (919) 684-8111 |
News Archive
Healthcare Technology firm TerraMedica LLC announced today that it has been awarded a contract by the U.S. Department of Health and Human Services (DHHS)/Office of the Assistant Secretary for Planning and Evaluation. TerraMedica will conduct an assessment of fraud, waste, and abuse in Medicare claims utilizing a pre-payment predictive scoring system.
A recent study by Kessler Foundation researchers explored numerous factors that contribute to the high unemployment rate among individuals of different ages with multiple sclerosis.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
Progenics Pharmaceuticals, Inc. today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet.
› Verified 2 days ago
Dr. Karen Christine Baker, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5704 Fayetteville Rd, Durham, NC 27713 Phone: 919-572-4673 Fax: 919-668-0321 | |
Tom Spalding, P.A. Urology Medicare: Not Enrolled in Medicare Practice Location: 205 Frasier St, Triangle Urology Associates, P.a., Durham, NC 27704 Phone: 919-477-7003 Fax: 919-471-2827 | |
Dr. Thomas James Polascik, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Duke Cancer Center 5-1 Urology, Duke Cancer Center, Duke University Medical Center, Durham, NC 27710 Phone: 919-684-4946 Fax: 919-684-5220 | |
Brant A Inman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 Trent Dr, Durham, NC 27710 Phone: 919-684-8111 | |
Dr. Andrew Charles Peterson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 40 Duke Medicine Cir, Durham, NC 27710 Phone: 919-684-2516 | |
Judd Moul, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 | |
Daniel George, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Duke University Medical Ctr, Durham, NC 27710 Phone: 919-620-4467 |